Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase

Journal of Clinical Investigation

Volumn 102, Issue 12, 1998, Pages 2061-2071

  Ohashi, Yoshitaka ^a   Kawashima, Seinosuke ^a   Hirata, Ken Ichi ^a   Yamashita, Tomoya ^a   Ishida, Tatsuro ^a   Inoue, Nobutaka ^a   Sakoda, Tsuyoshi ^a   Kurihara, Hiroki ^b   Yazaki, Yoshio ^b   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Blood pressure; Endothelium; Nitric oxide; Transgenic animals; Vascular reactivity

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; HYPOTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032535435     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4394     Document Type: Article

References (11)

1. Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
2. Dinerman, J.L., C.J. Lowenstein, and S.H. Snyder. 1993. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ. Res. 73:217-222.
3. Dzau, V.J., and G.H. Gibbons. 1991. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 18(Suppl. III):III115-III121.
4. Nathan, C, and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:915-918.
5. Moncada, S., and E.A. Hiegs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
6. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
7. Shesely, E.G., N. Maeda, H.S. Kim, K.M. Desai, J.H. Krege, V.E. Laubach, P.A. Sherman, W.C. Sessa, and O. Smithies. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Nail. Acad. Sci. USA. 93:13176-13181.
8. von der Leyen, H.E., G.H. Gibbons, R. Morishita, N.P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J.P. Cooke, and V.J. Dzau. 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA. 92:1137-1141.
9. Lin, K.-F., L. Chao, and J. Chao. 1997. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension. 30:307-313.
10. Ooboshi, H., Y. Chu, D. Rios, F.M. Faraci, B.L. Davidson, and D.D. Heistad. 1997. Altered vascular function after adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am. J. Physiol. 273(Heart Circ. Physiol. 42):H265-H270.
11. Harats, D., H. Kurihara, P. Belloni, H. Oakley, A. Ziober, D. Ackley, G. Cain, Y. Kurihara, R. Lawn, and E. Sigal. 1995. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J. Clin. Invest. 95:1335-1344.